American Well Corporation

American Well Corporation(AMWL)股票分析

$12.350

-0.378 (-3.06%)收盘时

Loading chart…
最高
13.810
开盘
12.590
成交量加权均价
12.65
成交量
181.78K
市值
111.26M
最低
11.800
成交额
2.30M
企业价值/息税折旧摊销前利润(TTM)
-2.67

American Well Corporation operates a hybrid care, delivery enablement platform in the United States and globally, connecting and enabling providers, payers, patients, and innovators to deliver access to more affordable quality care. It offers a single, comprehensive platform to support all digital health needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. The Amwell Converge platform offers data architecture and video capabilities, flexibility and scalability, as well as a user experience focused on the needs of patients, members and providers. For health systems, its enterprise platform enables provider-to-provider virtual care for use cases ranging from stroke to virtual nursing and e-sitting. Its Amwell Carepoint devices enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings, helping to address personnel shortages and access limitations.

AI 分析 of American Well Corporation (AMWL)

持有

American Well Corp is currently a hold. The stock is priced at $12.52, which is below the average analyst price target of $12, indicating limited upside potential in the near term. The RSI is at 37.8, suggesting the stock is nearing oversold territory, but the recent 5-day change of -7.53% indicates downward momentum. The company has shown improvement with a narrowed net loss of $9.6 million in Q2 2026, but risks remain due to ongoing losses and competitive pressures in the telehealth market.

估值指标

American Well Corporation(AMWL)当前预期市盈率为 0.00,5 年平均预期市盈率为 -9.48。

预期市盈率

合理
5 年均值 P/E
-9.48
当前P/E
0.00
高估
16.43
低估
-35.40

预期 EV/EBITDA

低估
5 年均值 EV/EBITDA
-0.18
当前EV/EBITDA
-2.67
高估
2.24
低估
-2.60

预期市销率

合理
5 年均值 P/S
1.69
当前P/S
1.02
高估
3.23
低估
0.15

Alphio AI 对 AMWL 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%AMWL

$8.60

情景价格

基

基准

基准 · 50%AMWL

$7.73

情景价格

悲

悲观

悲观 · 25%AMWL

$7.23

情景价格

持有 AMWL 的大户

C

Cable Car Capital LLC

+ 持有AMWL

-4.58%

3个月收益率

S

Senvest Management, LLC

+ 持有AMWL

-5.89%

3个月收益率

事件时间线

2026-11-03 (ET)

17:00:00

Company Sees Q4 Adjusted EBITDA of $0M-$1M

17:00:00

Company Raises 2026 Revenue Outlook to $203.15M

17:00:00

Amwell Reports Q3 Revenue of $48.99M, Beating Expectations

2026-09-08 (ET)

08:30:00

Amwell to Deploy Virtual Health Platform for VA

2026-08-04 (ET)

17:00:00

Amwell Reports Q2 Revenue of $52.05M, Exceeding Expectations

资讯

AMWL 常见问题 —— 由 Alphio AI 解答

American Well Corporation operates a hybrid care, delivery enablement platform in the United States and globally, connecting and enabling providers, payers, patients, and innovators to deliver access to more affordable quality care. It offers a single, comprehensive platform to support all digital health needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. The Amwell Converge platform offers data architecture and video capabilities, flexibility and scalability, as well as a user experience focused on the needs of patients, members and providers. For health systems, its enterprise platform enables provider-to-provider virtual care for use cases ranging from stroke to virtual nursing and e-sitting. Its Amwell Carepoint devices enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings, helping to address personnel shortages and access limitations. It operates in the Healthcare sector (SERVICES-BUSINESS SERVICES, NEC industry).

American Well Corp is currently a hold. The stock is priced at $12.52, which is below the average analyst price target of $12, indicating limited upside potential in the near term. The RSI is at 37.8, suggesting the stock is nearing oversold territory, but the recent 5-day change of -7.53% indicates downward momentum. The company has shown improvement with a narrowed net loss of $9.6 million in Q2 2026, but risks remain due to ongoing losses and competitive pressures in the telehealth market.

暂无帖子

注册或登录后参与讨论

相关文章

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易